# Reproductive Technologies, Inc. – FDA Inspection, Nov 18, 2024

Source: https://www.keypedia.com/records/fda_inspections/reproductive-technologies-inc/dc81b15b-899c-4381-9a5f-624d46bbe7c2
Source feed: FDA_Inspections

> FDA inspection 1254426 of Reproductive Technologies, Inc., November 18, 2024. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 1271. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1254426
- Company Name: Reproductive Technologies, Inc.
- Inspection Date: 2024-11-18
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: San Francisco District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1153089 - 2021-09-13
- [FDA Inspection 1100185 - 2019-08-16](https://www.keypedia.com/records/fda_inspections/reproductive-technologies-inc/57e50f00-bfa5-4927-a5b1-3888f3de498b)
- FDA Inspection 983894 - 2016-09-08
- FDA Inspection 861157 - 2013-12-20
- FDA Inspection 768779 - 2012-02-17

## Related Officers

- [Emily S. McGann](https://www.keypedia.com/people/emily-s-mcgann/43891ff3-bd70-4337-b61c-e16cc7ad0468)

Company: https://www.keypedia.com/companies/reproductive-technologies-inc/81a46c28-125d-4e9e-ba8b-1d521dff2b44

Office: https://www.keypedia.com/offices/san-francisco-district-office/6f838e9c-aae1-4665-9c46-a51d43be02df
